Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The primary objective of this study is to test the hypothesis that administration of dexamethasone 20 mg is superior to a 6 mg dose in adult patients with moderate or severe ARDS due to confirmed COVID-19. The secondary objective is to investigate the efficacy and safety of dexamethasone...

Descripción completa

Detalles Bibliográficos
Autores principales: Maláska, Jan, Stašek, Jan, Duška, František, Balík, Martin, Máca, Jan, Hruda, Jan, Vymazal, Tomáš, Klementová, Olga, Zatloukal, Jan, Gabrhelík, Tomáš, Novotný, Pavel, Demlová, Regina, Kubátová, Jana, Vinklerová, Jana, Svobodník, Adam, Kratochvíl, Milan, Klučka, Jozef, Gál, Roman, Singer, Mervyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917377/
https://www.ncbi.nlm.nih.gov/pubmed/33648568
http://dx.doi.org/10.1186/s13063-021-05116-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917377/
https://www.ncbi.nlm.nih.gov/pubmed/33648568
http://dx.doi.org/10.1186/s13063-021-05116-9

Ejemplares similares